- All sections
- C - Chemistrymetallurgy
- C07F - Acyclic, carbocyclic, or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium
- C07F 9/142 - Esters of phosphorous acids with hydroxyalkyl compounds without further substituents on alkyl
Patent holdings for IPC class C07F 9/142
Total number of patents in this class: 27
10-year publication summary
0
|
1
|
3
|
0
|
1
|
1
|
3
|
2
|
3
|
1
|
2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
Owner |
All patents
|
This class
|
---|---|---|
Lanxess Corporation | 271 |
3 |
Glaxosmithkline Intellectual Property Development Limited | 766 |
2 |
Dow Global Technologies LLC | 10437 |
2 |
Avantama AG | 48 |
2 |
BASF SE | 21017 |
1 |
Genentech, Inc. | 4009 |
1 |
Samsung SDI Co., Ltd. | 8622 |
1 |
Monsanto Technology LLC | 8290 |
1 |
Idemitsu Kosan Co., Ltd. | 4237 |
1 |
Curis, Inc. | 132 |
1 |
Dover Chemical Corporation | 60 |
1 |
INVISTA Technologies S.a.r.l. | 414 |
1 |
Lewis & Clark College | 5 |
1 |
Maruzen Petrochemical Co., Ltd. | 186 |
1 |
National University Corporation Okayama University | 461 |
1 |
Rhodia Operations | 1586 |
1 |
United Phosphorus, Ltd. | 32 |
1 |
Zhejiang Nhu Company Limited | 173 |
1 |
Jiangsu Jinghong New Material Technology Co., Ltd. | 6 |
1 |
Shandong Nhu Pharmaceutical Co., Ltd. | 25 |
1 |
Other owners | 2 |